https://pubmed.ncbi.nlm.nih.gov/21584937/
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program
GSK923295A demonstrated significant antitumor activity against solid tumor models, inducing CRs in Ewing sarcoma, rhabdoid, and rhabdomyosarcoma xenografts....
of the